[{"Assets_0_Q2_USD":192570000.0,"CommonStockSharesOutstanding_0_Q2_shares":56850172.0,"NetCashProvidedByUsedInOperatingActivities_1_Q2_USD":-17605000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-34185000.0,"NetIncomeLoss_1_Q2_USD":-23315000.0,"NetIncomeLoss_2_Q2_USD":-46566000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":56805583.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":56275795.0,"StockholdersEquity_0_Q2_USD":164466000.0,"EarningsPerShareBasic_1_Q2_USD":-0.46,"EarningsPerShareBasic_2_Q2_USD":-0.92,"Ticker":"ABUS","CIK":"1447028","name":"ARBUTUS BIOPHARMA CORP","OfficialName":"Arbutus Biopharma Corporation Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"388180699.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20190805"}]